Sunac Therapeutics
Biotechnology Research • 
Salt Lake City, Utah, United States • 1-10 Employees
Company overview
| Headquarters | Salt Lake City, Utah, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Sunac Therapeutics
Robby Bowles
Scientific Founder
About Sunac Therapeutics
Sunac is a seed-stage biotech developing a first-in-class, single-dose regenerative therapy that restores cellular health and function. Starting with degenerative disc disease, we’re building a pipeline to treat all major OA joints, with a clear path to clinical readiness.
$
Sunac Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Sunac Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Sunac Therapeutics has never raised funding before.
Australia
Sweden
United Kingdom
South AfricaFrequently asked questions
Sunac Therapeutics is located in Salt Lake City, Utah, US.
Sunac Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Sunac Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
